Document is current
Any future updates will be listed below
-
Authors
Dasgupta, Anandaroop
Kaushik, Ankita
Pandey, Shubhram
Attri, Sumeet
Miller, Paul
Tolley, Keith
-
Funding
Funding for this research was provided by:
Gilead Sciences, Inc.
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 26 August 2025
First Online: 4 September 2025
Declarations
:
: Anandaroop Dasgupta and Ankita Kaushik are employees of Gilead Sciences, Inc., and hold stock with Gilead Sciences, Inc. Shubhram Pandey and Sumeet Attri are employees of Pharmacoevidence, who provided support in data collection and editing, which was funded by Gilead Sciences, Inc. Paul Miller is affiliated with Miller Economics Limited. Keith Tolley is affiliated with Tolley Limited. Both Paul Miller and Keith Tolley received financial compensation from Gilead Sciences, Inc., to provide scientific advice on the project.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
